Photo Illustration: Sarah Grillo. Photos: NICHOLAS KAMM/AFP via Getty Images and Mark Wilson/Getty Images

Neither Congress nor the Trump administration is likely to get much done this year on drug prices, despite the clear political upside to doing so.

Between the lines: Polls consistently show that drug prices are a top concern for voters. President Trump and House Speaker Nancy Pelosi also seem to agree a lot on the policy. But a deal keeps getting further away.

Where it stands: The House is set to vote on Pelosi's bill next week, though if push ever comes to shove, she has a small and diminishing incentive to help Trump claim a big victory right before his reelection campaign.

  • The White House has thrown its weight behind a bipartisan bill in the Senate, but leadership has never been particularly warm to that effort, and rank-and-file Republicans have also backed away from parts of the plan.

The big picture: The pharmaceutical industry almost always gets its way in Washington.

  • The industry's top two trade organizations, together, spent more than $35 million on lobbying in 2018, more than they've ever spent before.
  • That doesn't include individual companies' contributions, nor does it include any of the industry's campaign contributions, which are substantial.

Trump's regulatory agenda on drug prices isn't faring much better. The administration has abandoned several of its ideas.

  • It's now working on a proposal to tie Medicare's payments to the prices European countries pay, but Trump would probably need a second term in order to see that one through.

And prices keep going up. The most expensive drug in the world — a gene replacement therapy that treats spinal muscular atrophy — came to market earlier this year, with a sticker price of $2.1 million in the U.S.

  • That drug is a groundbreaking new therapy, but prices also continue to rise for old, familiar products that people depend on every day — most notably, insulin.

Go deeper:

Go deeper

Marjorie Taylor Greene wins Georgia's 14th district runoff

Photo: Elijah Nouvelage / Getty Images

Gun-rights activist Marjorie Taylor Greene defeated physician John Cowan in a runoff election for the Republican nomination in Georgia's deep-red 14th Congressional District on Tuesday, AP reports.

Why it matters: Greene, a vocal QAnon conspiracy theorist who has been condemned by GOP leaders for making multiple offensive remarks about Black people, Jews and Muslims in Facebook videos, is likely to win a seat in the House come November.

Updated 6 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 20,207,011 — Total deaths: 738,910— Total recoveries: 12,452,222Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 5,140,512 — Total deaths: 164,502 — Total recoveries: 1,714,960 — Total tests: 63,252,257Map.
  3. States: Georgia reports 137 coronavirus deaths, setting new daily record Florida reports another daily record for deaths.
  4. Health care: Trump administration buys 100 million doses of Moderna's coronavirus vaccine.
  5. Business: Moderna reveals it may not hold patent rights for vaccine.
  6. Sports: Big Ten scraps fall football season.
  7. World: Anthony Fauci "seriously" doubts Russia's coronavirus vaccine is safe
Updated 48 mins ago - Health

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand Prime Minister Jacinda Ardern said it's too early to say whether next month's elections will be postponed after she announced Tuesday four people had tested positive for COVID-19 after no local cases for 102 days.

Zoom in: NZ's most populous city, Auckland, has gone on lockdown for 72 hours and the rest of the country is under lesser restrictions.